肝癌
- 造模剂
- N-Nitrosodiethylamine
- Thioacetamide
- 2-Acetamidofluorene
- Aristolochic acid A
- 抗病毒感染 [1]
- NCCN指南推荐 [2]
-
- FOLFOX4方案
- 5-FU
- Folinic acid
- Oxaliplatin
- 化疗
- 免疫检查点抑制剂
- 抗血管生成
- 靶向突变基因 [3] [4]
-
- Beta-catenin
- PRI-724
- RCM-1
- LF3
- Tegatrabetan
- MSAB
-
- FGFR2
- NSC12
- SKLB 610
- Alofanib
- Pemigatinib
- ASP5878
-
- PBRM1
- ACBI1
- 抗血管生成 (B)
-
- Angiotensin
- Angiotensin II human Acetate
- Angiotensin
- Azilsartan
- Olmesartan
- TKIs
- PI3K/Akt/mTOR
-
- DNA-PK
- Nedisertib
- T0070907
- Samotolisib
- Torin 2
- PP121
- MAPK
- Cell Cycle
-
- DNA/RNA Synthesis
- PF-562271
- Cisplatin
- Gemcitabine
- 5-FU
- Cycloheximide
- mAb & ADC
-
- VEGFR
- Bevacizumab
- Ramucirumab
- 相关化合物库
- FDA-approved Anticancer Drug Library
- Anti-cancer Compound Library
- Anti-cancer Compound Library-Ⅱ
- Anti-cancer Metabolism Compound Library
- Cambridge Cancer Compound Library
- Small Molecule Immuno-Oncology Compound Library
- Tyrosine Kinase Inhibitor Library
- Angiogenesis Related compound Library
- MAPK Inhibitor Library
- PI3K/Akt Inhibitor Library